237 related articles for article (PubMed ID: 32660827)
21. Genotoxic and carcinogenic effects of gastrointestinal drugs.
Brambilla G; Mattioli F; Martelli A
Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
[TBL] [Abstract][Full Text] [Related]
22. Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics.
Brambilla G; Martelli A
Pharmacol Res; 2009 Jul; 60(1):1-17. PubMed ID: 19427580
[TBL] [Abstract][Full Text] [Related]
23. An integrative test strategy for cancer hazard identification.
Luijten M; Olthof ED; Hakkert BC; Rorije E; van der Laan JW; Woutersen RA; van Benthem J
Crit Rev Toxicol; 2016 Aug; 46(7):615-39. PubMed ID: 27142259
[TBL] [Abstract][Full Text] [Related]
24. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity.
Ellinger-Ziegelbauer H; Aubrecht J; Kleinjans JC; Ahr HJ
Toxicol Lett; 2009 Apr; 186(1):36-44. PubMed ID: 18822359
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
[TBL] [Abstract][Full Text] [Related]
26. Establishing a quantitative framework for regulatory interpretation of genetic toxicity dose-response data: Margin of exposure case study of 48 compounds with both in vivo mutagenicity and carcinogenicity dose-response data.
Chepelev N; Long AS; Beal M; Barton-Maclaren T; Johnson G; Dearfield KL; Roberts DJ; van Benthem J; White P
Environ Mol Mutagen; 2023 Jan; 64(1):4-15. PubMed ID: 36345771
[TBL] [Abstract][Full Text] [Related]
27. [Efficiency of the prediction of carcinogenic activities of chemical substances based on scoring somatic mutations in the soybean Glycine max (L.) Merrill].
Bittueva MM; Abilev SK; Tarasov VA
Genetika; 2007 Jan; 43(1):78-87. PubMed ID: 17333942
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the sensitivity and specificity of in vivo erythrocyte micronucleus and transgenic rodent gene mutation tests to detect rodent carcinogens.
Morita T; Hamada S; Masumura K; Wakata A; Maniwa J; Takasawa H; Yasunaga K; Hashizume T; Honma M
Mutat Res Genet Toxicol Environ Mutagen; 2016 May; 802():1-29. PubMed ID: 27169373
[TBL] [Abstract][Full Text] [Related]
29. Rational approach to the quantification of genotoxicity.
Benigni R
Environ Mol Mutagen; 1992; 19(1):83-9. PubMed ID: 1732108
[TBL] [Abstract][Full Text] [Related]
30. In vitro genotoxicity testing-Can the performance be enhanced?
Corvi R; Madia F
Food Chem Toxicol; 2017 Aug; 106(Pt B):600-608. PubMed ID: 27554597
[TBL] [Abstract][Full Text] [Related]
31. A deep dive into historical Ames study data for N-nitrosamine compounds.
Tennant RE; Ponting DJ; Thresher A
Regul Toxicol Pharmacol; 2023 Sep; 143():105460. PubMed ID: 37495012
[TBL] [Abstract][Full Text] [Related]
32. In silico prediction of chromosome damage: comparison of three (Q)SAR models.
Morita T; Shigeta Y; Kawamura T; Fujita Y; Honda H; Honma M
Mutagenesis; 2019 Mar; 34(1):91-100. PubMed ID: 30085209
[TBL] [Abstract][Full Text] [Related]
33. In vivo genotoxicity testing strategies: Report from the 7th International workshop on genotoxicity testing (IWGT).
Kirkland D; Uno Y; Luijten M; Beevers C; van Benthem J; Burlinson B; Dertinger S; Douglas GR; Hamada S; Horibata K; Lovell DP; Manjanatha M; Martus HJ; Mei N; Morita T; Ohyama W; Williams A
Mutat Res Genet Toxicol Environ Mutagen; 2019 Nov; 847():403035. PubMed ID: 31699340
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of non-commercial models for genotoxicity and carcinogenicity in the assessment of EFSA's databases.
Carnesecchi E; Raitano G; Gamba A; Benfenati E; Roncaglioni A
SAR QSAR Environ Res; 2020 Jan; 31(1):33-48. PubMed ID: 31766891
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the miniaturized liquid Ames microplate format (MPF™) for a selection of the test items from the recommended list of genotoxic and non-genotoxic chemicals.
Spiliotopoulos D; Koelbert C
Mutat Res Genet Toxicol Environ Mutagen; 2020; 856-857():503218. PubMed ID: 32928366
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
37. Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Mutagenesis; 2012 Jul; 27(4):387-413. PubMed ID: 22228823
[TBL] [Abstract][Full Text] [Related]
38. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines.
Doak SH; Manshian B; Jenkins GJ; Singh N
Mutat Res; 2012 Jun; 745(1-2):104-11. PubMed ID: 21971291
[TBL] [Abstract][Full Text] [Related]
39. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
Kim BS; Margolin BH
Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
[TBL] [Abstract][Full Text] [Related]
40. A review of the genotoxicity of marketed pharmaceuticals.
Snyder RD; Green JW
Mutat Res; 2001 May; 488(2):151-69. PubMed ID: 11344042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
